Beigene адр (ONC) Bɛn Dɛŋɛn Akɔc
Beigene
Bɛ̈ny cɔk aya$360.85Aciic 25 Sep 2026
Change+0.24%
AI forecast: ONC
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
BeiGene, Ltd. is a commercial-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of molecularly targeted and immuno-oncology therapies for the treatment of cancer. BeiGene serves patients worldwide.
